Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Debt to Equity (2016 - 2022)

Fennec Pharmaceuticals' Debt to Equity history spans 8 years, with the latest figure at $8.92 for Q3 2022.

  • For the quarter ending Q3 2022, Debt to Equity changed N/A year-over-year to $8.92, compared with a TTM value of $8.92 through Sep 2022, changed N/A, and an annual FY2017 reading of $6.24, up 67420.14% over the prior year.
  • Debt to Equity for Q3 2022 was $8.92 at Fennec Pharmaceuticals, up from $0.59 in the prior quarter.
  • The five-year high for Debt to Equity was $8.92 in Q3 2022, with the low at $0.4 in Q1 2022.